- Query in any language with multilingual search
- Access EUR-Lex and EU Commission case law
- See relevant paragraphs highlighted instantly
Similar Documents
Explore similar documents to your case.We Found Similar Cases for You
Case T-662/16: Action brought on 12 September 2016 — Gall Pharma v EUIPO — Pfizer (Styriagra)
ECLI:EU:UNKNOWN:62016TN0662
62016TN0662
With us you find everything. Try it now!
I imagine what I want to write in my case, I write it in the search engine and I get exactly what I wanted. Thank you!
Valentina R., lawyer
28.11.2016
EN
Official Journal of the European Union
C 441/19
(Case T-662/16)
(2016/C 441/24)
Language in which the application was lodged: German
Parties
Applicant: Gall Pharma GmbH (Judenburg, Austria) (represented by: D. Reichelt and L. Figura, lawyers)
Defendant: European Union Intellectual Property Office (EUIPO)
Other party to the proceedings before the Board of Appeal: Pfizer Inc. (New York, New York, United States)
Details of the proceedings before EUIPO
Applicant for registration of the trade mark at issue: Applicant
Trade mark at issue: EU word mark ‘Styriagra’ — EU trade mark application No 12 161 469
Proceedings before EUIPO: Opposition proceedings
Contested decision: Decision of the Fifth Board of Appeal of EUIPO of 13 June 2016 in Case R 724/2015-5
Form of order sought
The applicant claims that the Court should:
—annul the contested decision and reject the opposition (Opposition Procedure No 002286568) to Community trade mark No 000233890;
—order the defendant to pay the costs.
Pleas in law
—Infringement of Article 8(5) of Regulation No 207/2009;
—Infringement of Article 8(1)(b) of Regulation No 207/2009.